Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 4, 1998, Pages 1173-1176

  Weidemann, Wolfgang ^a   Peters, Birgit ^a   Romalo, Gabriela ^b   Spindler, Klaus Dieter ^c   Schweikert, Hans Udo ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANDROGEN; ANDROGEN RECEPTOR; ARGININE; DNA; GLUTAMINE; GUANINE; LIPID; STEROID 5ALPHA REDUCTASE; TESTOSTERONE ENANTATE;

ADULT; AGED; ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CASE REPORT; DNA BINDING; DNA SEQUENCE; DRUG MEGADOSE; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRILIZATION;

ADULT; AMINO ACID SUBSTITUTION; ANDROGEN-INSENSITIVITY SYNDROME; ARGININE; CODON; DNA-BINDING PROTEINS; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 0031765296     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.4.1173     Document Type: Article

References (23)

1. Gottlieb B, Trifiro M, Lumbroso R, Pinsky L. 1947 The androgen receptor gene mutations database. Nucleic Acids Res. 25:158-162.
2. Quigley CA, De Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS. 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev. 16:271-321.
3. Weidemann W, Linck B, Haupt H, et al. 1996 Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. Clin Endocrinol (Oxf). 45:733-739.
4. Reifenstein EC. 1947 Hereditary familial hypogonadism. Proc Am Fed Clin Res. 3:86.
5. Schweikert HU. 1979 Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin. Horm Metab Res. 11:635-640.
6. Bhasin S, Bremner WJ. 1997 Emerging issues in androgen replacement therapy. J Clin Endocrinol Metab. 82:3-8.
7. Bagatell CJ, Bremner WJ. 1996 Androgens in men: uses and abuses. N Engl J Med. 334:707-714.
8. Nieschlag E, Behre HM, eds. 1990 Testosterone, action, deficiency, substitution. Berlin, Heidelberg: Springer-Verlag.
9. Price P, Wass JA, Griffin JE, et al. 1984 High dose androgen therapy in male pseudohermaphroditism due to a 5α-reductase deficiency and disorders of the androgen receptor. J Clin Invest. 74:1496-1508.
10. Grino PB, Isidro-Gutierrez RF, Griffin JE, Wilson JD. 1989 Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. J Clin Endocrinol Metab. 68:578-584.
11. Pinsky L, Kaufman M, Killinger DW. 1989 Impaired spermatogenesis is not an obligate expression of receptor-defective androgen resistance. Am J Med Genet. 32:100-104.
12. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Isidro-Gutierrez RF, Wilson JD. 1991 Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. J Clin Invest. 87:1413-1421.
13. Hiort O, Huang Q, Sinnecker GHG, et al. 1993 Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy. J Clin Endocrinol Metab. 77:262-266.
14. Radmayr C, Seibold J, Hobisch A, Bartsch G, Klocker H. 1996 Reactivation of two mutant androgen receptors by high dose androgen concentrations: a molecular basis for a treatment of a male pseudohermaphroditism patient with a qualitative androgen receptor defect. J Urol. 155:391A.
15. Tincello DG, Saunders PTK, Hodgins MB, et al. 1997 Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome. Clin Endocrinol (Oxf). 46:497-506.
16. Poujol N, Lobaccaro J-M, Chiche L, Lumbroso S, Sultan C. 1997 Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Mol Cell Endocrinol. 130:43-51.
17. Winter JSD, Fallman C. 1972 Pituitary gonadal relations in male children and adolescence. Pediatr Res. 6:126-129.
18. Sutherland RS, Kogani BA, Baskin LS, et al. 1996 The effect of prebutertal androgen exposure on adult penile length. J Urol. 156:783-787.
19. Wooster R, Mangion J, Eeles R, et al. 1992 A germlike mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet. 2:132-134.
20. McLachlan S-A, Erlichman C, Liu F-F, Miller N, Pintilie M. 1996 Male breast cancer: an 11 year review of 66 patients. Breast Cancer Res Treat. 40:225-230.
21. Lobaccaro J-M, Lumbroso S, Belon C, et al. 1993 Androgen receptor gene mutation in male breast cancer. Hum Mol Genet. 2:1799-2802.
22. Lobaccaro J-M, Lumbroso S, Belon C, et al. 1993 Male breast cancer and the androgen receptor gene. Nat Genet. 5:109-110.
23. Lubahn DB, Brown TR, Simental JA, et al. 1989 Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA. 86:9534-9538.